Unfortunately, apart from orthotopic liver transplantation (OLT), there are no universally accepted therapies to treat this disease. Even following transplantation, recurrence of PSC is seen in ...

Within our institution, vancomycin is generally considered the ... the American Society of Health-System Pharmacists (ASHP), Infectious Diseases Society of America (IDSA), and Society of ...

V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization.

A recent study by a team from Chiba University has demonstrated a promising approach for fighting antibiotic resistance by identifying a compound, V-161, that inhibits a sodium-pumping enzyme critical ...

Looking at the universe of stocks we cover at Dividend Channel, in trading on Wednesday, shares of Veris Residential Inc (Symbol: VRE) were yielding above the 2% mark based on its quarterly ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Purpose. The feasibility of using a limitedsampling algorithm for administration of vancomycin for treatment of vascular-access-related bacteremia in outpatient high flux hemodialysis was ...

Liver disease is any disease that directly affects your liver. Unlike acute liver failure, which happens suddenly, liver disease progresses slowly over time. Some types of liver disease ...

The International Classification of Diseases (ICD) system standardizes ... V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE ...